Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 2;13(1):65.
doi: 10.3390/microorganisms13010065.

Implementation of 2% Chlorhexidine Bathing to Reduce Healthcare-Associated Infections Among Patients in the Intensive Care Unit

Affiliations

Implementation of 2% Chlorhexidine Bathing to Reduce Healthcare-Associated Infections Among Patients in the Intensive Care Unit

Hsu-Liang Chang et al. Microorganisms. .

Abstract

Healthcare-associated infections (HAIs) significantly increase morbidity, mortality, length of hospital stays, and costs, particularly among ICU patients. Despite standard interventions, catheter-associated urinary tract infections (CAUTI) and central line-associated bloodstream infections (CLABSI) remain major HAI contributors. This study evaluated the efficacy of daily 2% chlorhexidine gluconate (CHG) bathing in reducing HAI incidence, specifically CAUTI, CLABSI, and multidrug-resistant organisms (MDROs), in a 20-bed ICU at a regional hospital. Using a prospective, uncontrolled before-and-after design, we compared traditional soap-water bathing (pre-intervention period) with CHG bathing over a one-year intervention and one-year post-intervention follow-up. The total number of patients and patient days admitted to the ICU per year were around 1330-1412 patients and 6702-6927 patient days, respectively, during 2018-2020. Results showed a significant reduction in HAI incidence rates from 3.43‱ to 0.58‱ (p < 0.05) during the intervention and sustained benefits post-intervention. Incidences of CAUTI and CLABSI decreased markedly (p < 0.05), with reduced MDRO isolates, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococci, carbapenem-resistant Acinetobacter baumannii, and Pseudomonas aeruginosa. Our findings support the implementation of daily CHG bathing as an effective strategy to reduce HAI and MDROs in ICU settings.

Keywords: catheter-associated bloodstream infections; catheter-associated urinary tract infections; chlorhexidine gluconate; healthcare-associated infections; multidrug-resistant organisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The processes of 2% chlorhexidine daily bathing.
Figure 2
Figure 2
The healthcare-associated infection densities and catheter-associated infection densities over the study periods.
Figure 3
Figure 3
The forest plot of meta-analysis on the effectiveness of chlorhexidine bathing for preventing urinary tract infections [13,14,15,16,17,18,19,20,21,22,23,24,25].

References

    1. Taiwan Centers for Diseases Control Annual Report of Nosocomial Infections Surveillance System. [(accessed on 24 April 2024)];2019 Available online: https://www.cdc.gov.tw/En/Category/Page/J63NmsvevBg2u3I2qYBenw.
    1. Huang S.S., Septimus E., Hayden M.K., Kleinman K., Sturtevant J., Avery T.R., Moody J., Hickok J., Lankiewicz J., Gombosev A., et al. Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: An analysis of a cluster-randomised trial. Lancet Infect. Dis. 2016;16:70–79. doi: 10.1016/S1473-3099(15)00238-8. - DOI - PubMed
    1. Raines K., Rosen K. The effect of chlorhexidine bathing on rates of nosocomial infections among the critically ill population. An analysis of current clinical research and recommendations for practice. Dimens. Crit. Care Nurs. 2016;35:84–91. doi: 10.1097/DCC.0000000000000165. - DOI - PubMed
    1. Van den Poel B., Saegeman V., Schuermans A. Increasing usage of chlorhexidine in health care settings: Blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control. Eur. J. Clin. Microbiol. Infect. Dis. 2022;41:349–362. doi: 10.1007/s10096-022-04403-w. - DOI - PubMed
    1. Bouadma L., Karpanen T., Elliott T. Chlorhexidine use in adult patients on ICU. Intensive Care Med. 2018;44:2232–2234. doi: 10.1007/s00134-018-5137-5. - DOI - PubMed

LinkOut - more resources